Delivery Order SPE2DB22D1017-SPE2DB23FG4CE
Award Date 9/27/23
Potential Completion Date 9/28/23
Potential Value $222
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $76,320 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 90 boxes of 5mg finasteride tablets. The place of performance is Amerisourcebergen's office in Conshohocken, Pennsylvania, with delivery required between July 25-26, 2023. As a major supplier of pharmaceuticals to the Department of Defense, this order for a common prostate medication supports DLA's mission to provide medical supplies to military treatment facilities worldwide....
- The Defense Logistics Agency awarded a $294,240 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 90 boxes of 5mg finasteride tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is July 19-20, 2023. This delivery order was issued against an existing DLA pharmaceuticals contract vehicle to supply the Defense Department with prescription medications in support of its healthcare programs. No set aside...
- The Defense Logistics Agency awarded a $305,280 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 90 boxes of 5mg finasteride tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is July 19-20, 2023. This delivery order was issued against an existing prime vendor contract vehicle to supply pharmaceutical products to various Department of Defense components. No set aside designation or subcontractors...
- The Defense Logistics Agency Troop Support Medical awarded a $12,720 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 90 boxes of 5 mg finasteride tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 24-25, 2023. This delivery order was issued against an existing Prime Vendor contract vehicle to supply pharmaceutical products and services in support of the Department of Defense's...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $323,210 to Amerisourcebergen Drug Corporation for the procurement of 90 5mg Finasteride tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance for this order is one day, from July 11, 2023 through July 12, 2023. As the DLA is the logistics combat support agency of the Department of Defense, this order was likely placed to support the...
- The Defense Logistics Agency, a combat support agency within the Department of Defense, awarded a $162,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 90 boxes of 5 mg finasteride tablets. The place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The period of performance is July 6-7, 2023. No set aside designation or subcontractors are indicated. This order is likely in support of the DLA's medical supply chain responsibilities...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at approximately $576 to provide 90 tablets of 5 mg finasteride. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance is August 15-16, 2023. As the DLA supports the Department of Defense by procuring medical supplies and pharmaceuticals, this order for the prostate medication finasteride is likely in support of DOD...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $19,080 to Amerisourcebergen Drug Corporation for the supply of 90 boxes of 5mg finasteride tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from June 21, 2023 through June 22, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency manages the global supply chain for the United States...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $19,000 to Amerisourcebergen Drug Corporation for the supply of 90 boxes of 5mg finasteride tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 3, 2023 through July 5, 2023. No set aside designation or subcontractors are indicated. The Defense Logistics Agency manages the global supply chain for the United States...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $63,600 to Amerisourcebergen Drug Corporation to supply 90 packages of 5mg finasteride tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is July 7-10, 2023. This delivery order was issued against an existing DLA contract vehicle to fulfill the agency's pharmaceutical supply needs. As the prime contractor, Amerisourcebergen will be responsible...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB23FG4CEDelivery Order
The Defense Logistics Agency awarded a $221,520 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 90 boxes of 5mg finasteride tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between September 27-28, 2023. This order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products to DLA and the Department of Defense more broadly. No set aside designation or subcontractors were identified. The award will help the DLA maintain readiness of military treatment facilities by providing a commonly prescribed medication to manage symptoms of benign prostatic hyperplasia.
Generated 12/27/23, 9:32 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $222 | 9/27/23 |